Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Veterinary Oncology Market, by Region, 2020-2028 (USD Million)
1.2.2. Veterinary Oncology Market, by Therapy, 2020-2028 (USD Million)
1.2.3. Veterinary Oncology Market, by Animal Type, 2020-2028 (USD Million)
1.2.4. Veterinary Oncology Market, by Cancer Type, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Veterinary Oncology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Veterinary Oncology Market Dynamics
3.1. Veterinary Oncology Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing pervasiveness of cancer in the pet population
3.1.1.2. Growing expenditure on animal healthcare
3.1.2. Market Challenges
3.1.2.1. High cost of veterinary cancer therapy
3.1.2.2. Side effects of oncology medications including as hair loss, decreased appetite, and vomiting
3.1.3. Market Opportunities
3.1.3.1. Increasing number of veterinary clinical studies for evaluating safety and efficacy of different oncologic treatments in pets.
3.1.3.2. Supportive government initiatives pertinent to veterinary cancer treatment
Chapter 4. Global Veterinary Oncology Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Veterinary Oncology Market, by Therapy
6.1. Market Snapshot
6.2. Global Veterinary Oncology Market by Therapy, Performance - Potential Analysis
6.3. Global Veterinary Oncology Market Estimates & Forecasts by Therapy 2018-2028 (USD Million)
6.4. Veterinary Oncology Market, Sub Segment Analysis
6.4.1. Surgery
6.4.2. Radiotherapy
6.4.3. Chemotherapy
6.4.4. Immunotherapy
6.4.5. Others
Chapter 7. Global Veterinary Oncology Market, by Animal Type
7.1. Market Snapshot
7.2. Global Veterinary Oncology Market by Animal Type, Performance - Potential Analysis
7.3. Global Veterinary Oncology Market Estimates & Forecasts by Animal Type 2018-2028 (USD Million)
7.4. Veterinary Oncology Market, Sub Segment Analysis
7.4.1. Canine
7.4.2. Feline
Chapter 8. Global Veterinary Oncology Market, by Cancer Type
8.1. Market Snapshot
8.2. Global Veterinary Oncology Market by Cancer Type, Performance - Potential Analysis
8.3. Global Veterinary Oncology Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Million)
8.4. Veterinary Oncology Market, Sub Segment Analysis
8.4.1. Lymphoma
8.4.2. Mast Cell Cancer
8.4.3. Mammary and Squamous Cell Cancer
8.4.4. Others
Chapter 9. Global Veterinary Oncology Market, Regional Analysis
9.1. Veterinary Oncology Market, Regional Market Snapshot
9.2. North America Veterinary Oncology Market
9.2.1. U.S. Veterinary Oncology Market
9.2.1.1. Therapy breakdown estimates & forecasts, 2018-2028
9.2.1.2. Animal Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Veterinary Oncology Market
9.3. Europe Veterinary Oncology Market Snapshot
9.3.1. U.K. Veterinary Oncology Market
9.3.2. Germany Veterinary Oncology Market
9.3.3. France Veterinary Oncology Market
9.3.4. Spain Veterinary Oncology Market
9.3.5. Italy Veterinary Oncology Market
9.3.6. Rest of Europe Veterinary Oncology Market
9.4. Asia-Pacific Veterinary Oncology Market Snapshot
9.4.1. China Veterinary Oncology Market
9.4.2. India Veterinary Oncology Market
9.4.3. Japan Veterinary Oncology Market
9.4.4. Australia Veterinary Oncology Market
9.4.5. South Korea Veterinary Oncology Market
9.4.6. Rest of Asia Pacific Veterinary Oncology Market
9.5. Latin America Veterinary Oncology Market Snapshot
9.5.1. Brazil Veterinary Oncology Market
9.5.2. Mexico Veterinary Oncology Market
9.6. Rest of The World Veterinary Oncology Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. PetCure Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Therapy Summary
10.2.1.5. Recent Developments
10.2.2. Zoetis
10.2.3. Karyopharm Therapeutics, Inc.
10.2.4. Varian Medical Systems
10.2.5. Accuray Incorporated
10.2.6. Boehringer Ingelheim GmbH
10.2.7. Elanco
10.2.8. One Health
10.2.9. Regeneus Ltd.
10.2.10. Morphogenesis, Inc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption